Correlation Between Four Leaf and Ventana Biotech

Can any of the company-specific risk be diversified away by investing in both Four Leaf and Ventana Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Four Leaf and Ventana Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Four Leaf Acquisition and Ventana Biotech, you can compare the effects of market volatilities on Four Leaf and Ventana Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Four Leaf with a short position of Ventana Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Four Leaf and Ventana Biotech.

Diversification Opportunities for Four Leaf and Ventana Biotech

-0.1

Correlation Coefficient

Four Leaf  Ventana Biotech

Good diversification

The 3 months correlation between Four and Ventana is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Four Leaf Acquisition and Ventana Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventana Biotech and Four Leaf is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Four Leaf Acquisition are associated (or correlated) with Ventana Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventana Biotech has no effect on the direction of Four Leaf i.e., Four Leaf and Ventana Biotech go up and down completely randomly.

Pair Corralation between Four Leaf and Ventana Biotech

Given the investment horizon of 90 days Four Leaf is expected to generate 1230.72 times less return on investment than Ventana Biotech. But when comparing it to its historical volatility, Four Leaf Acquisition is 954.2 times less risky than Ventana Biotech. It trades about 0.11 of its potential returns per unit of risk. Ventana Biotech is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  0.21  in Ventana Biotech on September 15, 2024 and sell it today you would lose (0.07) from holding Ventana Biotech or give up 33.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.46%
Values	Daily Returns

Four Leaf Acquisition  vs.  Ventana Biotech

Four Leaf Acquisition

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Four Leaf Acquisition are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Four Leaf is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Ventana Biotech

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Ventana Biotech are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ventana Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Four Leaf and Ventana Biotech

The main advantage of trading using opposite Four Leaf and Ventana Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Four Leaf position performs unexpectedly, Ventana Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventana Biotech will offset losses from the drop in Ventana Biotech's long position.

The idea behind Four Leaf Acquisition and Ventana Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.